Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Emanuel F. Petricoin, Corinne Ramos et al.|Clinical Cancer Research|2017Cited by 97
Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trialMariaelena Pierobon, Stephen P. Anthony, Ariane Kemkes et al.|Molecular Oncology|2021Cited by 14
Multi-omic profiling of metastatic lesions to guide treatment selection: The Side Out 2 trial experience.Mariaelena Pierobon, Stephen P. Anthony, Nicholas J. Robert et al.|Journal of Clinical Oncology|2018Cited by 4
Table S4 from Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Emanuel F. Petricoin, Corinne Ramos et al.|Unknown|2023Cited by 0
Figure S2 from Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Emanuel F. Petricoin, Corinne Ramos et al.|Unknown|2023Cited by 0